Eurofins Genomics

What Eurofins Genomics does

Eurofins Genomics is a wholly-owned subsidiary of Eurofins Scientific SE (Euronext Paris: EUFI) and a provider of genomic services founded in 1990, headquartered in Ebersberg, Germany. The company operates globally through dedicated regional websites and e-commerce storefronts for Europe, America, India, and Japan, employing more than 600 staff worldwide across core operating subsidiaries in Germany, shared services, and an India-based IT support entity.

The company offers a comprehensive portfolio spanning the genomics workflow: custom DNA and RNA oligonucleotide synthesis (including siRNA and an extensive catalog of fluorescent dyes, dark quenchers, and modifications) delivered in tubes or 96-well plates; Sanger and next-generation sequencing (NGS) services on Illumina and PacBio platforms; de novo gene synthesis with proprietary GENEius codon optimization and subcloning; genotyping and gene expression services; and molecular biology services including plasmid preparation, site-directed mutagenesis, and CRISPR-related products. Quality control relies on a barcode-driven high-throughput automated production system with MALDI-TOF MS verification, and laboratories hold ISO 17025, ISO 13485, GLP, GCP, and cGMP accreditations supporting clinical and regulated use cases.

The business model is primarily pay-as-you-go unit pricing across an e-commerce platform (Ecom) with quote-based enterprise ordering, supplemented by an EVOcard prepayment system. Revenue streams include custom oligo sales, sequencing services, gene synthesis, genotyping/gene expression services, and molecular biology services. The company serves four primary vertical segments — Pharma & Diagnostics, Agriculture & Food, Industrial Biotechnology, and Research — and participates in EU-funded research collaborations (FORECEE, HUMAN, Sybil, Eurofancolen, Net4CGD) that reinforce its position in clinical and academic genomics. Notable specialty offerings include Mycoplasmacheck qPCR contamination testing and the MitoSure-Human mitochondrial DNA pipeline developed in partnership with India's IGIB.

Name

Eurofins Genomics

Legal name

Eurofins Genomics Germany GmbH

Website

https://eurofinsgenomics.co.in

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

101–250 employees

Short description

Eurofins Genomics, founded in 1990 and headquartered in Germany, is a wholly-owned subsidiary of Eurofins Scientific SE providing custom oligonucleotide synthesis, Sanger and next-generation sequencing, gene synthesis, and molecular biology services to pharmaceutical, diagnostics, agriculture, industrial biotech, and research customers globally through a regional e-commerce platform.

Ownership category

akta.pro rank

Product category

Genomic Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Cytogenetics & Genomic Variation Services (Karyotyping/FISH/aCGH/CNV) (HLAGANAJ)

akta.pro secondary industries

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• DNA oligonucleotide synthesis
• Next generation sequencing
• Gene synthesis services
• Sanger sequencing services
• Molecular biology services

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Custom DNA/RNA Oligonucleotide Synthesis: Synthesis and sale of custom oligonucleotides including DNA oligos, RNA oligos, siRNA, and modified oligos with various purification options (Salt Free, HPSF, HPLC, PAGE)
2. DNA Sequencing Services: Sanger sequencing services (tube and plate formats) and next generation sequencing services
3. Gene Synthesis: Synthetic gene production including standard genes, express genes, GeneStrands, and subcloning services with 100% sequence accuracy verification
4. Genotyping & Gene Expression Services: SNP detection, microsatellite analysis, and gene expression profiling services
5. Molecular Biology Services: Including plasmid preparation, site-directed mutagenesis, and CRISPR-related services

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Eurofins Genomics is an international provider of genomic products and services, fundamentally selling custom DNA/RNA oligonucleotides (tubes and plates), Sanger and next-generation DNA sequencing services, synthetic gene production, and molecular biology services such as genotyping, gene expression analysis, and CRISPR-related work. The company's offerings serve pharmaceutical, clinical diagnostics, agriculture & food, industrial biotechnology, and academic research customers globally.

Product overview

Eurofins Genomics is a comprehensive genomic services provider offering a portfolio of interconnected products across the genomics workflow. The core offerings include Custom DNA/RNA Oligonucleotides (in tubes and plates) with extensive modification options, Sanger and Next Generation Sequencing services, Gene Synthesis with proprietary GENEius codon optimization, and Genotyping/Gene Expression services. The company operates through an e-commerce platform for ordering and provides specialty services including Mycoplasmacheck contamination testing and CRISPR experiment support. Services span from research-grade oligos to GMP-quality production, serving pharmaceutical, clinical diagnostics, agriculture, and research markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom DNA Oligos in Tubes Custom DNA oligonucleotides synthesized to customer specifications and delivered in 2ml screw cap tubes, with options for various purification methods, synthesis scales, and DNA modifications. Targeted at research and diagnostic laboratories needing standardized oligo delivery.
• Custom DNA Oligos in Plates Custom DNA oligos synthesized in 96-well plate formats with purification options including Salt Free, HPSF, and HPLC methods, designed for high-throughput applications in research and screening workflows.
• SeqPrimer Optimized primer specifically designed for Sanger DNA sequencing, validated to ensure optimum performance for detecting single base variants in PCR products, with accurate base detection and zero background sequence.
• siMAX siRNA Custom siRNA oligos for RNA interference applications, enabling gene silencing research for laboratories running RNAi experiments.
• Custom RNA Oligos Custom RNA oligonucleotides including O-Methyl-RNA and Chimeric RNA variants for various research applications in RNA biology and therapeutic research.
• Dual Labeled Probes qPCR probes with fluorescent dye and quencher combinations for quantitative real-time PCR applications.
• MGB Probes Minor Groove Binder probes providing enhanced specificity for SNP detection and pathogen identification in qPCR assays.
• NGSgrade Oligos Validated oligonucleotides optimized for next-generation sequencing applications with dedicated manufacturing quality standards.
• Gene Synthesis De novo gene synthesis service producing double-stranded DNA sequences up to several thousand base pairs, with codon optimization using proprietary GENEius software and options for cloning into customer-specified vectors.
• GeneStrands Synthetic linear dsDNA fragments delivered ready for cloning, with express turnaround times from 1-2 business days.
• Custom DNA Sequencing (Sanger) Sanger DNA sequencing services for samples submitted in tubes or 96-well plates, with options for tube sequencing and plate sequencing.
• Next Generation Sequencing (NGS) Comprehensive NGS services including whole genome sequencing, exome sequencing, targeted enrichment, transcriptome analysis, and metagenomics using Illumina and PacBio platforms.
• Genotyping Services SNP detection, microsatellite analysis, fragment length analysis, and STR analysis services for genetic variation studies.
• Gene Expression Services Services for analyzing gene expression patterns including transcriptomics and RNA sequencing.
• Molecular Biology Services Additional molecular biology services including plasmid preparation at various scales (mini to giga), site-directed mutagenesis, subcloning, and DNA/RNA isolation.
• Mycoplasmacheck qPCR-based mycoplasma detection service for cell culture contamination testing, detecting all mycoplasma species listed in European Pharmacopoeia 2.6.7 with detection sensitivity of 10 copies per reaction and results available within 48 hours.
• CRISPR Suite Comprehensive CRISPR-related products including synthetic genes, oligos, and services supporting CRISPR gene editing experiments.
• Site-Directed Mutagenesis (SDM) Mutagenesis service capable of mutating, inserting, or deleting up to 150 bp at target sites, with multi-SDM technology enabling simultaneous mutation of up to 5 sites.

Quantifiable outcome

• 100% sequence accuracy for cloned synthetic genes verified by double-stranded DNA sequencing
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• University College LondoncoreStrategic or Co-development Partner · 1 January 2020Eurofins GATC Biotech is a major collaborator in the FORECEE/4C research project, funded by the European Union (Horizon 2020). The project aims at developing a screening process for ovarian, cervical, endometrial and breast cancers. Eurofins performs analysis of vaginal microbiomes of 3,600 patients.
• The Eve AppealminorStrategic or Co-development Partner · 1 January 2020Co-funder of the FORECEE project along with Horizon 2020 for women's cancer screening research.
• Institute of Genomics and Integrative Biology (IGIB)coreStrategic or Co-development Partner · 27 July 2016Eurofins India announced association with India's leading research institute in Genomics (IGIB, New Delhi) to launch MitoSure-Human mitochondrial DNA sequencing and analysis pipeline for research and genetic screening purposes.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Twist Bioscience: Twist offers DNA synthesis on silicon platforms including oligos, GeneFragments, and clonal genes, directly challenging Eurofins' synthesis services with faster turnaround and lower cost at scale in synthetic biology.
• Integrated DNA Technologies (IDT): IDT is a leading global supplier of custom oligonucleotides, qPCR probes, and genomic services including NGS and gene synthesis—directly competing with Eurofins Genomics' core oligo and sequencing offerings to research and pharma customers.
• Macrogen: Macrogen is a Korea-based genomic services company specializing in DNA sequencing, NGS, and bioinformatics—directly competing with Eurofins Genomics' Sanger and NGS service lines across Asian and global research markets.
• Azenta Life Sciences (formerly GENEWIZ): Azenta (GENEWIZ) provides Sanger sequencing, NGS, gene synthesis, and synthetic biology services directly competing with Eurofins Genomics' sequencing and synthesis offerings to research customers globally.
• GenScript: GenScript is a major gene synthesis, oligo, and protein services provider competing head-to-head with Eurofins Genomics in synthetic biology, particularly for gene and gene-to-protein workflows serving pharma and academic customers.
• Bioneer: Bioneer provides custom oligo synthesis, gene synthesis, and molecular diagnostics services in Asia, offering similar product categories to Eurofins Genomics with regional pricing advantages in Korean and APAC markets.
• LGC Biosearch Technologies: LGC Biosearch Technologies provides custom oligos, qPCR probes (KASP genotyping), and genomics services directly competing with Eurofins' oligo and genotyping offerings, particularly in agricultural genomics.

Broad incumbents

• Eurofins Scientific SE: Eurofins Scientific is the publicly-traded parent of Eurofins Genomics operating in 44 countries with 45,000+ employees; broader Eurofins Testing Group offerings in food, pharma, and clinical testing share some customer overlap with the Genomics division.
• QIAGEN: QIAGEN provides oligo synthesis, sample-prep, and NGS-adjacent genomic services within its broader molecular diagnostics and sample technologies portfolio, competing with Eurofins in research and clinical genomics workflows.
• Thermo Fisher Scientific: Through its Life Sciences Solutions segment (including Applied Biosystems and GeneArt), Thermo Fisher offers oligos, sequencing, and gene synthesis as part of a much broader life sciences portfolio, overlapping with Eurofins Genomics on multiple product lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/eurofingenomics
• Facebookfacebook.com/EurofinsGenomics
• LinkedInlinkedin.com/company/eurofinsgenomics

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurofins Genomics